EG19645A - A method for preparing pharmaceutical by use bambuterol - Google Patents

A method for preparing pharmaceutical by use bambuterol

Info

Publication number
EG19645A
EG19645A EG14791A EG14791A EG19645A EG 19645 A EG19645 A EG 19645A EG 14791 A EG14791 A EG 14791A EG 14791 A EG14791 A EG 14791A EG 19645 A EG19645 A EG 19645A
Authority
EG
Egypt
Prior art keywords
bambuterol
preparing pharmaceutical
manufacture
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
EG14791A
Other languages
English (en)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Application granted granted Critical
Publication of EG19645A publication Critical patent/EG19645A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
EG14791A 1990-03-16 1991-03-13 A method for preparing pharmaceutical by use bambuterol EG19645A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9000948A SE9000948D0 (sv) 1990-03-16 1990-03-16 New use

Publications (1)

Publication Number Publication Date
EG19645A true EG19645A (en) 1995-09-30

Family

ID=20378886

Family Applications (1)

Application Number Title Priority Date Filing Date
EG14791A EG19645A (en) 1990-03-16 1991-03-13 A method for preparing pharmaceutical by use bambuterol

Country Status (28)

Country Link
US (2) US5837727A (cs)
EP (1) EP0521967B1 (cs)
JP (1) JP3081640B2 (cs)
KR (1) KR100194995B1 (cs)
AT (1) ATE138570T1 (cs)
AU (1) AU653149B2 (cs)
CA (1) CA2077762C (cs)
CZ (1) CZ279308B6 (cs)
DE (1) DE69119896T2 (cs)
DK (1) DK0521967T3 (cs)
EG (1) EG19645A (cs)
ES (1) ES2087291T3 (cs)
GR (1) GR3020700T3 (cs)
HK (1) HK52197A (cs)
HU (1) HU211998B (cs)
IE (1) IE80668B1 (cs)
IL (1) IL97509A (cs)
LT (1) LT3734B (cs)
LV (1) LV10917B (cs)
MY (1) MY114218A (cs)
NZ (1) NZ237279A (cs)
PT (1) PT97052B (cs)
RU (1) RU2093153C1 (cs)
SE (1) SE9000948D0 (cs)
SG (1) SG64895A1 (cs)
SK (1) SK278815B6 (cs)
WO (1) WO1991013615A1 (cs)
ZA (1) ZA911452B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9000948D0 (sv) * 1990-03-16 1990-03-16 Draco Ab New use
US6459316B1 (en) * 2000-12-08 2002-10-01 Intel Corporation Flip flop circuit
KR20040068240A (ko) * 2001-12-14 2004-07-30 노보 노르디스크 에이/에스 호르몬 민감성 리파아제의 활성을 감소시키기 위한 화합물및 그들의 사용
US7495028B2 (en) 2002-08-08 2009-02-24 Wen Tan R-bambuterol, its preparation and therapeutic uses
AU2002332488A1 (en) * 2002-08-08 2004-02-25 J. L. Cheng R-bambuterol, its preparation and therapeutic uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE7689T1 (de) * 1980-07-09 1984-06-15 Aktiebolaget Draco 1-(dihydroxyphenyl)-2-amino-aethanol-derivate, verfahren und mittel zu ihrer herstellung sowie diese derivate enthaltende mittel.
US4472436A (en) * 1982-12-06 1984-09-18 Neo-Bionics, Inc. Increasing HDL-cholesterol levels with phenylethylamine derivatives
EP0244062A3 (en) * 1986-03-03 1990-06-20 Beecham Group Plc Use of aryl ethanol amine derivatives in the treatment of atherosclerosis
SE9000948D0 (sv) * 1990-03-16 1990-03-16 Draco Ab New use

Also Published As

Publication number Publication date
EP0521967B1 (en) 1996-05-29
LV10917B (en) 1996-04-20
HU9202958D0 (en) 1992-12-28
LT3734B (en) 1996-02-26
NZ237279A (en) 1993-08-26
WO1991013615A1 (en) 1991-09-19
JPH05504971A (ja) 1993-07-29
LTIP1735A (en) 1995-07-25
GR3020700T3 (en) 1996-10-31
SE9000948D0 (sv) 1990-03-16
PT97052A (pt) 1991-10-31
CA2077762A1 (en) 1991-09-17
US5837727A (en) 1998-11-17
PT97052B (pt) 1998-07-31
SK278815B6 (sk) 1998-03-04
LV10917A (lv) 1995-12-20
KR100194995B1 (ko) 1999-06-15
DE69119896T2 (de) 1996-10-10
HU211998B (en) 1996-01-29
CS9100681A2 (en) 1991-10-15
RU2093153C1 (ru) 1997-10-20
CA2077762C (en) 2001-06-12
ATE138570T1 (de) 1996-06-15
AU653149B2 (en) 1994-09-22
EP0521967A1 (en) 1993-01-13
DE69119896D1 (de) 1996-07-04
IE910862A1 (en) 1991-09-25
IE80668B1 (en) 1998-11-18
HUT61461A (en) 1993-01-28
SG64895A1 (en) 2000-01-25
JP3081640B2 (ja) 2000-08-28
DK0521967T3 (da) 1996-09-09
IL97509A0 (en) 1992-06-21
MY114218A (en) 2002-09-30
HK52197A (en) 1997-05-02
ZA911452B (en) 1991-11-27
US6034123A (en) 2000-03-07
AU7569191A (en) 1991-10-10
ES2087291T3 (es) 1996-07-16
CZ279308B6 (cs) 1995-04-12
IL97509A (en) 1995-12-31

Similar Documents

Publication Publication Date Title
NO913668D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat for nasal tilfoersel.
AU3502289A (en) Method for administering the drug deprenyl so as to minimize the danger of side effects
NO885641L (no) Fremgangsmaate for fremstilling av farmasoeytisk preparat.
FI891538A0 (fi) Menetelmä farmaseuttisesti käyttökelpoisten fenolisubstituoitujen gem-difosfonaattijohdannaisten valmistamiseksi
HRP921250A2 (en) Process for the preparation of new pharmacologically active catechol derivatives
HU9202044D0 (en) Method for producing 4-phenyl-piperidine-4-carbixamide derivatives and pharmaceutical preparatives containing these compounds as active agents
AU3005492A (en) Process for the preparation of a pharmaceutical composition selectively lowering the blood lipid level
DE3880667D1 (de) Ampulle zur gesteuerten verabreichung eines heilmittels.
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
EG19645A (en) A method for preparing pharmaceutical by use bambuterol
ES542846A0 (es) Procedimiento para producir un preparado farmaceutico desti-nado a aplicacion por via topica
AU5992990A (en) 14,17alpha-etheno- and -ethanoestratrienes, processes for the preparation of these compounds, as well as their use for the production of medicinal agents
HUT49873A (en) Herbicides and acaricides, as well as process for producing the active ingredient aryl- or heteroaryldione derivatives
DE3064773D1 (en) Novel quinazoline derivatives, a pharmaceutical composition containing such derivatives as active ingredient and a process for producing the quinazoline derivatives
ES8105711A1 (es) Un metodo de preparar derivados de piperidina
HU9300388D0 (en) New medical preparatives with 5-(1-hydroxi-2-chlorine-ethyl)-4-methyl-triazole content and method for preparing them
JO1692B1 (en) Use of a pharmaceutically acceptable salt
PT67267B (en) Process for preparing the antibiotic 890a9 and the pharmaceutically acceptable salts thereof
GB2251621B (en) Process for the preparation of pyrethroid derivatives
DK171484A (da) Optisk fiberkabelkonstruktion
JO1652B1 (en) New compounds for local anesthesia and a way to prepare them
DK168486A (da) Indstilleligt lysarmatur
HUT50807A (en) Process for producing pharmaceutical compositions comprising labdane derivatives as active ingredient and for producing the active ingredient
HU905770D0 (en) Process for the production of a medical preparation
PT67268B (en) Process for preparing the antibiotic 890a10 and the pharmaceutically acceptable salts thereof